Back to results
US 2020/0399345 A1Published application
Methods of use of soluble cd24 for therapy of rheumatoid arthritis
AssigneeOncoimmune, Inc.
InventorsXincheng Zheng, Wei Wu, Yang Liu, Pan Zheng
Life of this patent
Estimating the term…
Abstract
Provided herein is a CD24 protein. The CD24 protein may include mature human or mouse CD24, as well as a N- or C-terminally fused portion of a mammalian immunoglobulin.
Claims10
A CD24 protein comprising a mature human CD24 variant consisting of SEQ II) NO:
- 1.
Dependencies are inferred from the claim text.